Wall Street drops as China stock slump stokes growth fears

By Noel Randewich

(Reuters) - Wall Street sank on Monday, with the Nasdaq losing almost 1 percent after the steepest decline in Chinese stocks in eight years increased concerns that cooling growth in the world's No. 2 economy could hurt China's trading partners.

The Dow Jones industrial average finished at its lowest level since February, and the S&P 500 chalked up a five-session losing streak for the first time since January.

In addition, 480 stocks hit 52-week lows on the New York Stock Exchange, the most in one day since Oct. 15. <.AD.N>

After Chinese stocks plunged more than 8 percent, the country's top securities regulator said Beijing would keep buying shares to stabilise the market as an unprecedented rescue plan already in place appeared to sputter.

Commodity prices resumed a downward spiral, with the Thomson Reuters CRB commodities index <.TRJCRB> hitting a six-year low and oil a four-month low.

"It's hard to assess whether China single-handedly can deep-six the market," said Chuck Carlson, chief executive at Horizon Investment Services in Hammond, Indiana. "A significant slowdown in China impacts not just the U.S. but global players as well."

The Dow Jones industrial average fell 0.73 percent to end at 17,440.59 points. The S&P 500 lost 0.58 percent to end at 2,067.64. The Nasdaq Composite dropped 0.96 percent to 5,039.78.

Nine of the 10 major S&P 500 sectors were lower, led by a 1.35 percent fall in the energy index <.SPNY>.

With second-quarter reports well under way, analysts expect overall earnings of S&P 500 companies to dip 0.3 percent and revenue to decline 3.9 percent, according to Thomson Reuters data.

Such results could inflate already relatively pricey valuations. The S&P 500 is trading near 16.9 times forward 12-month earnings, above the 10-year median of 14.7 times, according to StarMine data.

"Valuations are a concern right now," said Randy Frederick, managing director of trading and derivatives for Charles Schwab in Austin, Texas. "We really need to see corporate revenue growth."

The main event for U.S. markets this week is likely to be the two-day U.S. Federal Reserve meeting beginning on Tuesday, the last policy meeting before September, which still looms as the first possible date for an interest rate increase.

Teva Pharmaceutical's shares jumped 16.41 percent to a record high of $72.00 after the company agreed to buy Allergan's generic drug business for $40.5 billion, giving up on its bid to buy Mylan . Allergan rose 6.09 percent while Mylan fell 14.51 percent.

Fiat Chrysler fell 4.88 percent after a U.S. auto safety watchdog announced a $105 million fine against the automaker over lapses in safety recalls.

On the NYSE, 2.73 stocks fell for every one that rose. On the Nasdaq, decliners outnumbered gainers 2.47 to 1.

The S&P 500 index posted three new 52-week highs and 58 lows; the Nasdaq Composite saw 21 new highs and 246 lows.

Some 7.3 billion shares changed hands on U.S. exchanges, above the daily average of 6.6 billion so far this month.

(Additional reporting by Tanya Agrawal; Editing by Bernadette Baum, Nick Zieminski and Leslie Adler)